Ramaswami: At a time when the country is going through a grave crisi on the public health front, a “scandalous” amount of profiteering of almost 145% has come to light in the sale of rapid test kits for novel coronavirus or COVID-19 to government-owned Indian Council of Medical Research (ICMR), which is at the centre of handling the country’s battle against the contagious virus. According to report in Business Today, the rapid test kits, shipped from China, were sold to ICMR had heavily overpriced rates, forcing the Delhi HC to scale down the price by 33%. The massive profiteering was exposed in the court’s ruling on a dispute by the importer and distributor (Rare Metabolics vs Matrix Labs).